GO
| HSI1 | 25,889.48 | -400.84 | 490.37B |
| HSCEI1 | 9,222.54 | -135.78 | 194.82B |
| Back Zoom + Zoom - Block Traded | |
|
SIHUAN PHARM Joins Stake in Swiss Medical Aesthetic Firm Suisselle SA
2025-10-13 09:40:59 SIHUAN PHARM (00460.HK) announced that it made an equity investment in Swiss medical aesthetic company Suisselle SA in September 2025, and the parties have formally entered into an investment and subscription agreement. This collaboration will enhance the strategic relationship between SIHUAN PHARM and Suisselle to jointly explore the global medical aesthetic market. SIHUAN PHARM had previously obtained the exclusive distribution rights for the CELLBOOSTER skin booster in China back in 2022, according to the announcement. Through this equity investment, the group will own the permanent exclusive distribution rights of CELLBOOSTER skin booster products and will be deeply involved in its operation and development. ~ AAStocks Financial News Web Site: www.aastocks.com | |